World's Best Scientists 2026 revealed!
Tomoki Naoe

Tomoki Naoe

D-Index & Metrics

Medicine

D-Index
100
Citations
51556
World Ranking
8141
National Ranking
211

Tomoki Naoe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tomoki Naoe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 757 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tomoki Naoe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tomoki Naoe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tomoki Naoe is affiliated with Nagoya University in Japan, with a research focus primarily in the field of Medicine. Their work spans multiple subfields including Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health, and Rheumatology.

Their research topics concentrate mainly on blood cancers and related disorders, covering areas such as:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Renal and related cancers

The scientist has published frequently in venues well-regarded in hematology and oncology, including:

  • Cancer Science (8 publications)
  • Blood (5 publications)
  • Blood Advances (4 publications)
  • International Journal of Hematology (4 publications)
  • Cancer Immunology Immunotherapy (2 publications)

Some notable recent papers authored by Tomoki Naoe include:

  • "Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy" (2022, Blood)
  • "Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11" (2020, Blood Advances)
  • "Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations" (2021, Blood)
  • "Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia" (2021, Blood Advances)
  • "Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial" (2021, HemaSphere)

Tomoki Naoe collaborates regularly with several researchers, including:

  • Yasushi Miyazaki
  • Itaru Matsumura
  • Shigeki Ohtake
  • Kensuke Usuki
  • Nobuaki Dobashi

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

    Yukiya Yamamoto;Hitoshi Kiyoi;Yasuyuki Nakano;Ritsuro Suzuki

  • In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

    Guo-Qiang Chen;Jun Zhu;Xue-Geng Shi;Jian-Hua Ni

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

    Hitoshi Kiyoi;Tomoki Naoe;Yasuyuki Nakano;Shohei Yokota

  • Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells

    Guo-Qiang Chen;Xue-Geng Shi;Wei Tang;Shu-Min Xiong

  • let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

    Yukihiro Akao;Yoshihito Nakagawa;Tomoki Naoe

  • Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines.

    Fumihiko Hayakawa;Masayuki Towatari;Hitoshi Kiyoi;Mitsune Tanimoto

  • Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

    S Yokota;H Kiyoi;M Nakao;T Iwai

  • Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product.

    H Kiyoi;M Towatari;S Yokota;M Hamaguchi

  • High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

    Masamitsu Yanada;Jin Takeuchi;Isamu Sugiura;Hideki Akiyama

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

    Takashi Oyama;Kazuhito Yamamoto;Naoko Asano;Aya Oshiro

  • Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Miguel A. Sanz;Miguel A. Sanz;Pierre Fenaux;Martin S. Tallman;Elihu H. Estey

  • Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).

    H Kiyoi;T Naoe;S Yokota;M Nakao

  • EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

    Hiroshi Kimura;Yoshinori Ito;Shinji Kawabe;Kensei Gotoh

  • Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

    Tatsuya Suzuki;Hitoshi Kiyoi;Kazutaka Ozeki;Akihiro Tomita

  • MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers

    Yukihiro Akao;Yoshihito Nakagawa;Tomoki Naoe

  • Decreased expression of microRNA-143 and -145 in human gastric cancers.

    Takeshi Takagi;Akio Iio;Yoshihito Nakagawa;Tomoki Naoe

  • Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

    Hitoshi Kiyoi;Ryuzo Ohno;Ryuzo Ueda;Hidehiko Saito

Frequent Co-Authors

Tetsuhito Kojima
Tetsuhito Kojima Nagoya University
Ritsuro Suzuki
Ritsuro Suzuki Shimane University
Yukihiro Akao
Yukihiro Akao Gifu University
Kazuyuki Shimada
Kazuyuki Shimada Nagoya University
Yasuo Morishima
Yasuo Morishima Aichi Medical University
Ryuzo Ueda
Ryuzo Ueda Nagoya University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Hidehiko Saito
Hidehiko Saito Nagoya Medical Center
Masafumi Taniwaki
Masafumi Taniwaki Kyoto Prefectural University of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways and related degrees can open up flexible options for those interested in healthcare careers beyond the traditional route of studying Medicine in the USA. Many students opt for online programs to accommodate work and family responsibilities while progressing their education.

For registered nurses seeking career advancement, rn to bsn online programs offer an accessible and affordable way to earn a Bachelor of Science in Nursing. These programs help nurses develop leadership and clinical skills while maintaining employment.

Those who hold a non-nursing bachelor’s degree may consider online direct entry msn programs for non-nurses. These accelerated options provide a fast-track to becoming a registered nurse and earning a master’s degree.

If you are searching for programs with broader access, some nursing schools with high acceptance rates make it easier to gain admission and start your nursing education journey.

For those interested in healthcare but not in direct patient care roles, consider medical billing and coding schools online with financial aid. These programs train students for vital administrative positions and can often be completed from home.

Best Scientists Citing Tomoki Naoe

Trending Scientists

Recently Published Articles